SBIO ETF (ALPS Medical Breakthroughs ETF) is managed by ALPS Advisors with $149.0M in net assets. SBIO expense ratio is 0.50%, holding 88 positions across sectors including Health Care, Unknown. Inception date: 2014-12-30.

SBIO performance shows a YTD return of 0.36%. The 1-year return is 80.78% and the 5-year return is 2.11%. SBIO dividend yield stands at 4.05%, paid annually.

SBIO top holdings include Kymera Therapeutics Inccommon Stock (4.3%), Cg Oncology Inc (3.6%), Mirum Pharmaceuticals Inc (3.5%), Alkermes Plc (3.4%), Celcuity Inc Com (3.4%). View all SBIO holdings, sector breakdown, or dividend history.

SBIO can be compared against other funds using the overlap calculator or side-by-side comparison tool. SBIO alternatives are available via the screener, along with tax-loss harvesting opportunities.